BBIO
BridgeBio Pharma, Inc. Common Stock (BBIO) Investor Questions
Review BridgeBio Pharma, Inc. Common Stock (BBIO) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- BridgeBio Pharma, Inc. Common Stock
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 25
- Annual revenue
- $502.08M
- Annual net income
- $-732.94M
- Annual free cash flow
- $-447.01M
BridgeBio Pharma, Inc. Common Stock (BBIO) Investor Questions research
BridgeBio Pharma, Inc. Common Stock trades under the ticker BBIO. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review BBIO through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.